Two staged hepatectomy for colorectal hepatic metastases

  • Santiago Cubas Universidad de la República, Hospital de Clínicas, Clínica Quirúrgica B http://orcid.org/0000-0001-6026-5316
  • Fernando Bonilla Universidad de la República, Hospital de Clínicas, Clínica Quirúrgica B
  • Alonzo Rodríguez Universidad de la República, Facultad de Medicina, Hospital de Clínicas, Departamento de Imagenología
  • Luis Cazabán Universidad de la República, Facultad de Medicina, Hospital de Clínicas, Clínica Quirúrgica B
  • César Canessa Universidad de la República, Hospital de Clínicas, Clínica Quirúrgica B
Keywords: COLORECTAL NEOPLASMS, NEOPLASM METASTASIS, TWO-STAGE HEPATECTOMY, PORTAL VEIN, TREATMENT OUTCOME

Abstract

Treatment of colorectal hepatic metastases has gradually changed in the last 20 years. Nowadays, surgical treatment remains one of the major curative treatment options available to patients. Survival in patients who may undergo a surgical resection of the tumor may add up to 40% in 5 years’ time. These promising oncologic results have led surgical teams to make their best to achieve extreme liver resections which used to be contraindicated in the past. Thus, within this line of work, the liver remodeling surgery developed, which surgery consists in altering the portal flow aiming for a liver hypertrophy in the healthy liver and a liver atrophy of the sick liver. The following study aims to present one of the most frequent remodeling surgeries in the world: the two staged hepatectomy with portal flow occlusion. Indication, surgery opportunities, oncologic benefit and viability in our country are also discussed in the study.

References

(1) Renehan AG, Egger M, Saunders MP, O'Dwyer ST. Impact on survival of intensive follow up after curative resection for colorectal cancer: systematic review and meta-analysis of randomised trials. BMJ 2002; 324:813.

(2) Simmonds PC, Primrose JN, Colquitt JL, Garden OJ, Poston GJ, Rees M. Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies. Br J Cancer 2006; 94:982-99.

(3) Pawlik TM, Schulick RD, Choti MA. Expanding criteria for resectability of colorectal liver metastases. Oncologist 2008; 13:51-64. doi: 10.1634/theoncologist.2007-0142.

(4) Hadden WJ, de Reuver PR, Brown K, Mittal A, Samra JS, Hugh TJ. Resection of

colorectal liver metastases and extra-hepatic disease: a systematic review and

proportional meta-analysis of survival outcomes. HPB (Oxford) 2016; 18:209-20. doi: 10.1016/j.hpb.2015.12.004.

(5) Abdalla EK, Vauthey JN, Ellis LM, Ellis V, Pollock R, Broglio KR, Hess K, Curley SA. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 2004; 239:818-5.

(6) Jaeck D, Oussoultzoglou E, Rosso E, Greget M, Weber JC, Bachellier P. A two-stage hepatectomy procedure combined with portal vein embolization to achieve curative resection for initially unresectable multiple and bilobar colorectal liver metastases. Ann Surg 2004; 240(6):1037-49.

(7) Kianmanesh R, Farges O, Abdalla EK, Sauvanet A, Ruszniewski P, Belghiti J. Right portal vein ligation: a new planned two-step all-surgical approach for com- plete resection of primary gastrointestinal tumors with multiple bilateral liver metastases. J Am Coll Surg 2003; 197(1):164-70.

(8) Pawlik TM, Scoggins CR, Zorzi D, Abdalla EK, Andres A, Eng C, et al. Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg 2005; 241(5):715-22.

(9) Dahm F, Georgiev P, Clavien PA. Small-for-size syn- drome after partial liver transplantation: definition, mechanisms of disease and clinical implications. Am J

Transplant 2005; 5(11):2605-10.

(10) Balzan S, Belghiti J, Farges O, Ogata S, Sauvanet A, Delefosse D, et al. The "50-50 criteria" on postopera- tive day 5: an accurate predictor of liver failure and death after hepatectomy. Ann Surg 2005; 242(6):824-8.

(11) Rahbari NN, Garden OJ, Padbury R, Brooke-Smith M, Crawford M, Adam R, et al. Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery 2011; 149(5):713-24.

(12) de Santibañes E, Clavien PA. Playing Play-Doh to prevent postoperative liver failure: the "ALPPS" approach. Ann Surg 2012; 255(3):415-7.

(13) Adam R, Wicherts DA, de Haas RJ, Ciacio O, Levi F, Paule B, et al. Patients with initially unresectable colorectal liver metastases: is there a possibility of cure? J Clin Oncol 2009; 27(11):1829-35.

(14) Bipat S, van Leeuwen MS, Comans EF, Pijl ME, Bossuyt PM, Zwinderman AH, et al. Colorectal liver metastases: CT, MR imaging, and PET for diagno-sis-meta-analysis. Radiology 2005; 237(1):123-31.

(15) Breitenstein S, Apestegui C, Petrowsky H, Clavien PA. "State of the art" in liver resection and living donor liver transplantation: a worldwide survey of 100 liver centers. World J Surg 2009; 33(4):797-803.

Published
2019-04-07
How to Cite
1.
Cubas S, Bonilla F, Rodríguez A, Cazabán L, Canessa C. Two staged hepatectomy for colorectal hepatic metastases. Rev. Méd. Urug. [Internet]. 2019Apr.7 [cited 2024Dec.18];35(1):54-9. Available from: https://www2.rmu.org.uy/ojsrmu311/index.php/rmu/article/view/12